Transactions
May 14, 2015
Dealmakers
A roundup of recent transactions across the state and the lawyers involved.
Gibson counsels financial adviser in $8.4B pharma deal
Gibson, Dunn & Crutcher LLP represented Lazard Ltd. in connection with its role as
financial advisor to Alexion Pharmaceuticals Inc., which agreed to acquire Synageva
BioPharma Corp. for approximately $8.4 billion in cash and stock. The deal was announced
May 6.
Under the terms of th...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In